Cargando…
Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era
BACKGROUND: Nonpharmaceutical interventions to prevent the spread of coronavirus disease 2019 also decreased the spread of respiratory syncytial virus (RSV) and influenza. Viral diagnostic testing in patients with respiratory tract infections (RTI) is a necessary tool for patient management; therefo...
Autores principales: | Bernstein, David I, Mejias, Asuncion, Rath, Barbara, Woods, Christopher W, Deeter, Jamie Phillips |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384538/ https://www.ncbi.nlm.nih.gov/pubmed/35854475 http://dx.doi.org/10.1093/jalm/jfac058 |
Ejemplares similares
-
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008) -
Age and respiratory syncytial virus etiology in bronchiolitis clinical outcomes
por: Rodriguez-Fernandez, Rosa, et al.
Publicado: (2022) -
Respiratory Syncytial Virus bronchiolitis: Impact of second-hand smoke exposure on immune profiles
por: Diaz, Alejandro, et al.
Publicado: (2017) -
The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines
por: King, Tiffany, et al.
Publicado: (2021) -
Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
por: Garcia-Mauriño, Cristina, et al.
Publicado: (2019)